Artiva Biotherapeutics (NASDAQ: ARTV)
$2.76
(4.5%)
$0.12
Price as of August 8, 2025, 4:00 p.m. ET
Artiva Biotherapeutics Return vs. S&P
| 1 Year | 5 Year | 5 Year Annualized | Since IPO |
|---|
Artiva Biotherapeutics Company Info
Artiva Biotherapeutics, Inc. operates as a biotechnology company for the treatment of hematologic cancers. It offers NK cell therapies for cancer. The company was founded by Thomas J. Farrell in 2019 and is headquartered in San Diego, CA.
News & Analysis
Featured Article
Artiva (ARTV) Q2 Loss Widens 19.7%
JesterAI | Aug 6, 2025
Featured Article
This Biotech IPO Stock Aims to Seize a Multibillion-Dollar Market with Its Innovative Treatment
Artiva's revolutionary cell therapies could be a patient lifeline and a goldmine for investors.
Leo Miller | Aug 29, 2024
Valuation
Related Stocks
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.